Literature DB >> 3654969

Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men.

K R Segal1, A Dunaif, B Gutin, J Albu, A Nyman, F X Pi-Sunyer.   

Abstract

To clarify the independent relationships of obesity and overweight to cardiovascular disease risk factors and sex steroid levels, three age-matched groups of men were studied: (i) 8 normal weight men, less than 15% body fat, by hydrostatic weighing; (ii) 16 overweight, obese men, greater than 25% body fat and 135-160% of ideal body weight (IBW); and (iii) 8 overweight, lean men, 135-160% IBW, but less than 15% fat. Diastolic blood pressure was significantly greater for the obese (mean +/- SEM, 82 +/- 2 mmHg) than the normal (71 +/- 2) and overweight lean (72 +/- 2) groups, as were low density lipoprotein levels (131 +/- 9 vs. 98 + 11 and 98 + 14 mg/dl), the ratio of high density lipoprotein to total cholesterol (0.207 +/- 0.01 vs. 0.308 +/- 0.03 and 0.302 +/- 0.03), fasting plasma insulin (22 +/- 3 vs. 12 +/- 1 and 13 +/- 2 microU/ml), and the estradiol/testosterone ratio (0.076 +/- 0.01 vs. 0.042 +/- 0.02 and 0.052 +/- 0.02); P less than 0.05. Estradiol was 25% greater for the overweight lean group (40 +/- 5 pg/ml) than the obese (30 +/- 3 pg/ml) and normal groups (29 +/- 2 pg/ml), P = 0.08, whereas total testosterone was significantly lower in the obese (499 +/- 33 ng/dl) compared with the normal and overweight, lean groups (759 +/- 98 and 797 +/- 82 ng/dl). Estradiol was uncorrelated with risk factors and the estradiol/testosterone ratio appeared to be a function of the reduced testosterone levels in obesity, not independently correlated with lipid levels after adjustment for body fat content. Furthermore, no risk factors were significantly different between the normal and overweight lean groups. We conclude that (a) body composition, rather than body weight per se, is associated with increased cardiovascular disease risk factors; and (b) sex steroid alterations are related to body composition and are not an independent cardiovascular disease risk factor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654969      PMCID: PMC442345          DOI: 10.1172/JCI113159

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Estradiol-17-beta and estrone: studies on their binding to rabbit uterine cytosol and their concentration in plasma.

Authors:  N Nagai; C Longcope
Journal:  Steroids       Date:  1971-06       Impact factor: 2.668

2.  Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives.

Authors:  R R Tremblay; J Y Dube
Journal:  Contraception       Date:  1974-12       Impact factor: 3.375

3.  A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma.

Authors:  W Rosner
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

6.  Conversion of androstenedione to estrone by human tissue.

Authors:  A E Schindler; A Ebert; E Friedrich
Journal:  J Clin Endocrinol Metab       Date:  1972-10       Impact factor: 5.958

7.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

8.  Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study.

Authors:  S W Rabkin; F A Mathewson; P H Hsu
Journal:  Am J Cardiol       Date:  1977-03       Impact factor: 2.778

9.  Coronary and aortic atherosclerosis in relation to body-build factors.

Authors:  V Rissanen
Journal:  Ann Clin Res       Date:  1975-12

10.  Definition, measurement, and classification of the syndromes of obesity.

Authors:  G A Bray
Journal:  Int J Obes       Date:  1978
View more
  17 in total

1.  Survey of cardiac rehabilitation centers in New York City.

Authors:  B Gutin; L Prince; R Stein
Journal:  J Community Health       Date:  1990-08

Review 2.  Measuring growth and medium- and longer-term outcomes in malnourished children.

Authors:  Victor O Owino; Alexia J Murphy-Alford; Marko Kerac; Paluku Bahwere; Henrik Friis; James A Berkley; Alan A Jackson
Journal:  Matern Child Nutr       Date:  2019-02-27       Impact factor: 3.092

3.  The effect of ketoconazole and transdermal estradiol on serum sex steroid hormones levels.

Authors:  G S Hughes; S F Francom; C R Spillers; T V Ringer
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Characterization of metabolites and biomarkers for the probiotic effects of Clostridium cochlearium on high-fat diet-induced obese C57BL/6 mice.

Authors:  Fei Yang; Wenjun Zhu; Paba Edirisuriya; Qing Ai; Kai Nie; Xiangming Ji; Kequan Zhou
Journal:  Eur J Nutr       Date:  2022-03-20       Impact factor: 5.614

5.  Baseline estradiol concentration in community-dwelling Japanese American men is not associated with intra-abdominal fat accumulation over 10 years.

Authors:  Beverly M Kocarnik; Edward J Boyko; Alvin M Matsumoto; Wilfred Y Fujimoto; Tomoshige Hayashi; Donna L Leonetti; Stephanie T Page
Journal:  Obes Res Clin Pract       Date:  2015-12-31       Impact factor: 2.288

6.  Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes.

Authors:  Saori Maruo; Koka Motoyama; Tomoe Hirota; Yoshinori Kakutani; Yuko Yamazaki; Tomoaki Morioka; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto
Journal:  Diabetol Int       Date:  2020-03-21

7.  A 3-year follow-up study of inpatients with lower limb ulcers: evidence of an obesity paradox?

Authors:  Michelle Miller; Christopher Delaney; Deanna Penna; Lilian Liang; Jolene Thomas; Phillip Puckridge; James I Spark
Journal:  J Multidiscip Healthc       Date:  2012-08-09

8.  Body adiposity index utilization in a Spanish Mediterranean population: comparison with the body mass index.

Authors:  Angel A López; Mey L Cespedes; Teofila Vicente; Matias Tomas; Miguel Bennasar-Veny; Pedro Tauler; Antoni Aguilo
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

9.  Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance.

Authors:  Feifei Wang; Xiaojing Ma; Yaping Hao; Rong Yang; Jie Ni; Yunfeng Xiao; Junling Tang; Yuqian Bao; Weiping Jia
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

10.  Waist circumference and body mass index as predictors of health care costs.

Authors:  Betina Højgaard; Dorte Gyrd-Hansen; Kim Rose Olsen; Jes Søgaard; Thorkild I A Sørensen
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.